首页 | 本学科首页   官方微博 | 高级检索  
检索        

奈达铂联合紫杉醇和顺铂联合紫杉醇同步放化疗局部晚期鼻咽癌的临床随机对照实验
引用本文:邓颖,胡洪林,任刚,杨兰,潘海霞,朱学强.奈达铂联合紫杉醇和顺铂联合紫杉醇同步放化疗局部晚期鼻咽癌的临床随机对照实验[J].癌症进展,2011,9(4):445-447.
作者姓名:邓颖  胡洪林  任刚  杨兰  潘海霞  朱学强
作者单位:四川省人民医院肿瘤科,成都,610071;四川省人民医院肿瘤科,成都,610071;四川省人民医院肿瘤科,成都,610071;四川省人民医院肿瘤科,成都,610071;四川省人民医院肿瘤科,成都,610071;四川省人民医院肿瘤科,成都,610071
摘    要:目的 通过临床随机对照实验观察奈达铂是否能够替代顺铂与紫杉醇联合同步放化疗局部晚期鼻咽癌,是否能够提高治疗的耐受性.方法 实验组(TN组)30例,采用紫杉醇135 mg/m2ivgtt d1+奈达铂10 mg/m2 ivgttd1诱导化疗,每3周为1个化疗周期,共2个疗程,以后行同样方案同期放化疗,仍然每3周为1个化疗...

关 键 词:奈达铂  顺铂  紫杉醇  同步放化疗  鼻咽癌

Randomized controlled trials of nedaplatin combined with paclitaxel and cisplatin paclitaxel in concurrent chemoradiotherapy for local advanced nasopharyngeal carcinoma
Deng Ying,Hu Honglin,Ren Gang,Yang Lan,Pan Haixia,Zhu Xueqiang.Randomized controlled trials of nedaplatin combined with paclitaxel and cisplatin paclitaxel in concurrent chemoradiotherapy for local advanced nasopharyngeal carcinoma[J].Oncology Progress,2011,9(4):445-447.
Authors:Deng Ying  Hu Honglin  Ren Gang  Yang Lan  Pan Haixia  Zhu Xueqiang
Institution:Deng Ying Hu Honglin Ren Gang Yang Lan Pan Haixia Zhu Xueqiang Department of Oncology, Sichuan People's Hospital, Chengdu 610071 , China
Abstract:Objective To explore whether nedaplatin combined with paclitaxel can replace cisplatin plus paclitaxel in concurrent chemoradiotherapy for local advanced nasopharyngeal cancer,and whether it can improve the tolerance of treatment.Methods Thirty patients in the experimental group(TN group) were given paclitaxel(135 mg/m2 ivgtt dl) and nedaplatin(10 mg/m2 ivgtt dl).every 3 weeks for a chemotherapy cycle,a total of 2 courses,after the same program line chemoradiotherapy still every 3 weeks for a chemotherapy c...
Keywords:nedaplatin cisplatin paclitaxel concurrent chemoradiotherapy nasopharyngeal carcinoma  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号